Coyne Terrance P.
EVP & CFO · 37 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | RPRX | Royalty Pharma plc | Sale | 64,399 | $53.98 | $3.5M | filing |
| 2026-05-06 | RPRX | Royalty Pharma plc | Award | 24,263 | $0.00 | $0.00 | filing |
| 2026-04-28 | RPRX | Royalty Pharma plc | Sale | 32,916 | $49.78 | $1.6M | filing |
| 2026-04-28 | RPRX | Royalty Pharma plc | Sale | 1,875 | $49.78 | $93,334.50 | filing |
| 2026-04-01 | RPRX | Royalty Pharma plc | Sale | 32,916 | $48.33 | $1.6M | filing |
| 2026-04-01 | RPRX | Royalty Pharma plc | Sale | 1,875 | $48.33 | $90,622.13 | filing |
| 2026-03-23 | RPRX | Royalty Pharma plc | Sale | 32,916 | $45.53 | $1.5M | filing |
| 2026-03-23 | RPRX | Royalty Pharma plc | Sale | 1,875 | $45.53 | $85,366.31 | filing |
| 2026-03-02 | RPRX | Royalty Pharma plc | Sale | 22,487 | $46.67 | $1.0M | filing |
| 2026-03-02 | RPRX | Royalty Pharma plc | Sale | 10,429 | $47.01 | $490,314.22 | filing |
| 2026-03-02 | RPRX | Royalty Pharma plc | Sale | 1,292 | $46.67 | $60,303.71 | filing |
| 2026-03-02 | RPRX | Royalty Pharma plc | Sale | 583 | $47.01 | $27,409.34 | filing |
| 2026-02-23 | RPRX | Royalty Pharma plc | Sale | 32,916 | $45.32 | $1.5M | filing |
| 2026-02-23 | RPRX | Royalty Pharma plc | Sale | 1,875 | $45.32 | $84,968.44 | filing |
| 2026-02-11 | RPRX | Royalty Pharma plc | Award | 26,626 | $0.00 | $0.00 | filing |
| 2026-02-04 | RPRX | Royalty Pharma plc | Sale | 19,076 | $43.29 | $825,853.45 | filing |
| 2026-02-04 | RPRX | Royalty Pharma plc | Sale | 1,087 | $43.29 | $47,059.27 | filing |
| 2026-02-03 | RPRX | Royalty Pharma plc | Sale | 108,759 | $42.84 | $4.7M | filing |
| 2026-02-03 | RPRX | Royalty Pharma plc | Sale | 6,195 | $42.84 | $265,413.00 | filing |
| 2026-02-02 | RPRX | Royalty Pharma plc | Sale | 102,581 | $42.08 | $4.3M | filing |
| 2026-02-02 | RPRX | Royalty Pharma plc | Sale | 5,843 | $42.08 | $245,896.23 | filing |
| 2026-01-20 | RPRX | Royalty Pharma plc | Sale | 65,832 | $39.35 | $2.6M | filing |
| 2026-01-20 | RPRX | Royalty Pharma plc | Sale | 3,750 | $39.35 | $147,556.50 | filing |
| 2026-01-02 | RPRX | Royalty Pharma plc | Sale | 65,832 | $38.42 | $2.5M | filing |
| 2026-01-02 | RPRX | Royalty Pharma plc | Sale | 3,750 | $38.42 | $144,058.88 | filing |
| 2025-12-15 | RPRX | Royalty Pharma plc | Sale | 65,832 | $38.36 | $2.5M | filing |
| 2025-12-15 | RPRX | Royalty Pharma plc | Sale | 3,750 | $38.36 | $143,850.38 | filing |
| 2025-12-01 | RPRX | Royalty Pharma plc | Sale | 65,832 | $39.87 | $2.6M | filing |
| 2025-12-01 | RPRX | Royalty Pharma plc | Sale | 3,750 | $39.87 | $149,497.50 | filing |
| 2025-11-24 | RPRX | Royalty Pharma plc | Sale | 55,146 | $38.67 | $2.1M | filing |
| 2025-11-24 | RPRX | Royalty Pharma plc | Sale | 10,686 | $37.96 | $405,644.83 | filing |
| 2025-11-24 | RPRX | Royalty Pharma plc | Sale | 3,126 | $38.67 | $120,882.11 | filing |
| 2025-11-24 | RPRX | Royalty Pharma plc | Sale | 624 | $37.96 | $23,686.73 | filing |
| 2025-11-17 | RPRX | Royalty Pharma plc | Sale | 65,844 | $39.30 | $2.6M | filing |
| 2025-11-17 | RPRX | Royalty Pharma plc | Sale | 3,750 | $39.30 | $147,390.00 | filing |
| 2025-11-05 | RPRX | Royalty Pharma plc | Award | 6,168 | $0.00 | $0.00 | filing |
| 2025-08-06 | RPRX | Royalty Pharma plc | Award | 3,696 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.